Vitor Rosa, MD, PhD, FESC Profile
Vitor Rosa, MD, PhD, FESC

@vitoremer

Followers
165
Following
888
Media
14
Statuses
123

Cardiologist, valvular heart disease enthusiat, and dad of Rafael and Felipe

São Paulo, Brasil
Joined June 2009
Don't wanna be here? Send us removal request.
@vitoremer
Vitor Rosa, MD, PhD, FESC
1 year
RT @3i_incor: No novo episódio do #PodcastTripleI, o Dr. @vitoremer explica quais são os sintomas da #EstenoseAórtica, como surgem e os pos….
0
1
0
@vitoremer
Vitor Rosa, MD, PhD, FESC
1 year
RT @3i_incor: O estudo #DEDICATE avaliou as duas abordagens para o tratamento de #EstenoseAórtica, e você pode conferir os destaques dessa….
0
1
0
@vitoremer
Vitor Rosa, MD, PhD, FESC
1 year
RT @3i_incor: Confira os destaques do estudo #DEDICATE, que avalia as abordagens para o tratamento de #EstenoseAórtica! .Para se aprofundar….
0
2
0
@vitoremer
Vitor Rosa, MD, PhD, FESC
2 years
RT @3i_incor: Neste episódio da série “5 Minutos em Valvopatia”, o @vitoremer da equipe #3i, apresenta a parte 1 dos destaques do congress….
Tweet card summary image
triplei.com.br
Saiba os principais estudos sobre Valvopatias no Congresso TCT 2023. Assista ao vídeo!
0
2
0
@grok
Grok
9 hours
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
45
24
261
@vitoremer
Vitor Rosa, MD, PhD, FESC
2 years
RT @3i_incor: Seguindo a nossa série “5 Minutos em #Valvopatia”, confira a segunda parte dos destaques do congresso #TCT2023. Desta vez,….
Tweet card summary image
triplei.com.br
Veja o que o Dr. Vitor Rosa apresentou durante o Congresso TCT 2023 sobre Valvopatias em um vídeo de 5 minutos. Descubra os estudos TRISCEN...
0
1
0
@vitoremer
Vitor Rosa, MD, PhD, FESC
2 years
RT @3i_incor: No vídeo “TAVI na #estenoseaórtica de baixo risco”, do #3i Dr. @vitoremer traz uma discussão dos resultados do seguimento de….
0
1
0
@vitoremer
Vitor Rosa, MD, PhD, FESC
2 years
RT @3i_incor: Temos um convite especial pra você! Dr. @vitoremer e o Prof. @DrAlexandreAbiz, médicos do time #3i, farão uma live intitulada….
0
2
0
@vitoremer
Vitor Rosa, MD, PhD, FESC
2 years
RT @3i_incor: Vitor Rosa, M.D., discusses highlights from the #AmericanCollegeofCardiology 2023 -
0
1
0
@vitoremer
Vitor Rosa, MD, PhD, FESC
2 years
RT @3i_incor: "What is #HeydeSyndrome?” is today's #TripleI article theme, by Lynnie Arouca, M.D. e Vitor Emer Rosa , M.D. - .
0
1
0
@vitoremer
Vitor Rosa, MD, PhD, FESC
2 years
RT @3i_incor: ”#MajorAorticStenosis with #VentricularDysfunction: is there any room for #vasodilators?" is today's #TripleI article, by Vit….
0
1
0
@vitoremer
Vitor Rosa, MD, PhD, FESC
2 years
RT @3i_incor: #TAVI in #cardiogenicshock: new therapeutic option for patients with #aorticstenosis in a critical scenario" is today's #Trip….
0
1
0
@vitoremer
Vitor Rosa, MD, PhD, FESC
2 years
RT @3i_incor: ”What is the best treatment for #ProstheticValveThrombosis: #thrombolysis or #surgery?" is today's #TripleI article, by Lynni….
0
1
0
@vitoremer
Vitor Rosa, MD, PhD, FESC
2 years
RT @3i_incor: Do you know the #QuinckeSign? Press play and check out the material produced by the #TripleI team -
Tweet card summary image
instagram.com
0
1
0
@vitoremer
Vitor Rosa, MD, PhD, FESC
2 years
RT @3i_incor: ”Is it possible to treat endocarditis at home?” Is today's #TripleI article, by Fernanda Tessari M.D., and Vitor Rosa, M.D.….
Tweet card summary image
triplei.com.br
0
1
0
@vitoremer
Vitor Rosa, MD, PhD, FESC
2 years
RT @PPibarot: Just presented at TCT and published in Circulation: Primary results of the VIVA trial: Transcatheter or Surgical Aortic Valve….
Tweet card summary image
ahajournals.org
BACKGROUND: The optimal treatment in patients with severe aortic stenosis and small aortic annulus (SAA) remains to be determined. This study aimed to compare the hemodynamic and clinical outcomes...
0
16
0
@vitoremer
Vitor Rosa, MD, PhD, FESC
2 years
RT @FrontCVMedicine: New Research: Multimodality imaging methods and systemic biomarkers in classical low-flow low-gradient aortic stenosis….
0
1
0
@vitoremer
Vitor Rosa, MD, PhD, FESC
2 years
RT @FrontCVMedicine: New Research: Risk prediction in patients with classical low-flow, low-gradient aortic stenosis undergoing surgical in….
Tweet card summary image
frontiersin.org
Introduction: Classical low-flow, low-gradient aortic stenosis (LFLG-AS) is an advanced stage of aortic stenosis, which has not only a poor prognosis with me...
0
1
0
@vitoremer
Vitor Rosa, MD, PhD, FESC
2 years
RT @FrontCVMedicine: New Research: B-type natriuretic peptide and N-terminal Pro-B-type natriuretic peptide in severe aortic stenosis: a co….
Tweet card summary image
frontiersin.org
B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-pro BNP) are cardiac biomarkers that are released in response to increased ventricular and atrial...
0
3
0
@vitoremer
Vitor Rosa, MD, PhD, FESC
2 years
RT @tietamedeiros: Very happy with our paper published at Frontiers @FrontiersIn.Thanks to all the authors. Special thanks to my mentors,….
0
1
0
@vitoremer
Vitor Rosa, MD, PhD, FESC
3 years
RT @lucasfresno: To chorando q nem um neném aqui - pqp é o filho do cara 😢
0
14K
0